Effects of Nigella Sativa oil and Docosahexaenoic acid on experimentally-induced hepatic fibrosis in rats

Authors

  • Eman Gouda Khedr Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt
  • Ghada Mohammad Al-Ashmawy Department of Biochemistry, Faculty of Pharmacy, Tanta University, Tanta, Egypt
  • Sally El-Sayed Abu-Risha Department of Pharmacology and Toxicology, Faculty of Pharmacy, Tanta University, Tanta, Egypt
  • Abla Ebeed Department of Clinical Pharmacy, Faculty of Pharmacy, Delta University, Egypt
  • Marwa Salah Department of Pathology, Faculty of Medicine, Menofeya University, Egypt

DOI:

https://doi.org/10.56511/JIPBS.2019.v6.i03.pp24-29

Abstract

Hepatic fibrosis is a consequence of chronic liver injury. Peroxisome proliferator activated receptor-gamma (PPAR-γ) may play a role in the pathogenesis of hepatic fibrosis. Activation of endothelial progenitor cell (EPC) mobilization can contribute to hepatic regeneration after fibrotic injury. However, the potential benefits of docosahexaenoic acid (DHA) and Nigella Sativa oil (NS), naturally-derived oil, in ameliorating fibrosis remain elusive. Liver fibrosis was induced in rats by oral administration of 50% CCl4 three times per week for 8 weeks. The rats intoxicated with CCl4 were divided into three groups: fibrosis control, DHA, and NS groups. A fourth group of normal healthy rats served as a control group. The results showed that Nigella Sativa oil significantly decreased serum albumin, alanine aminotransferase (ALT), and bilirubin levels in the NS-treated group compared to those in the fibrosis control group. Liver histopathology and EPC immunohistochemistry supported these biochemical data. A significant increase in PPAR- γ was found in the DHA and NS groups. The results indicate that the NS oil treatment produced a more substantial effect than DHA treatment and has a beneficial role in inhibiting or reversing liver fibrosis

Keywords:

Nigella Sativa, Docosahexaenoic acid, Liver fibrosis, PPAR-γ, CD34

Downloads

Download data is not yet available.

References

Pellicoro A, Ramachandran P and Iredale JP: Reversibility of liver fibrosis. Fibrogenesis Tissue Repair 2012; 5(1): S26-S30.

Schuppan D and Afdhal NH: Liver cirrhosis. Lancet (London, England) 2008; 371(9615): 838 – 851.

Yin C, Evason KJ, Asahina K and Stainier DYR: Hepatic stellate cells in liver development, regeneration, and cancer.J. Clin. Invest. 2013; 123(5): 1902 – 1910.

Simard T, Jung RG, Motazedian P, Di Santo P, Ramirez FD, Russo JJ, Labinaz A, Yousef A, Anantharam B, Pourdjabbar A and Hibbert B: Progenitor cells for arterial repair: Incremental advancements towards therapeutic reality. Stem Cells Int. 2017; 2017: 1 – 14.

Rennert RC, Sorkin M, Garg RK and Gurtner GC: Stem cell recruitment after injury: Lessons for regenerative medicine. Regen. Med. 2012; 7(6): 833 – 850.

Zhu Y, Ni Y, Liu R, Hou M, Yang B, Song J, Sun H, Xu Z and Ji M: PPAR- γ agonist alleviates liver and spleen pathology viainducing Treg cells during Schistosoma japonicum infection. J. Immunol. Res. 2018; 2018: 1 – 11.

Chen H, He YW, Liu WQ and Zhang JH: Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. World J. Gastroenterol. 2008; 14(18): 2905 – 2911.

Wang Z, Xu JP, Zheng YC, Chen W, Sun YW, Wu ZY and Luo M: Peroxisome proliferator-activated receptor gamma inhibits hepatic fibrosis in rats. Hepatobiliary Pancreat. Dis. Int. 2011; 10(1): 64 – 71.

Dollah MA, Parhizkar S, Latiff LA and Bin Hassan MH: Toxicity effect of nigella sativa on the liver function of rats. Adv. Pharm. Bull. 2013; 3(1): 97 – 102.

Bedossa P and Poynard T: An algorithm for the grading of activity in chronic hepatitis C. Hepatology 1996; 24(2): 289 – 293.

Wanless IR, Nakashima E, and Sherman M: Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.Arch. Pathol. Lab. Med. 2000; 124(11): 1599 – 1607.

Sun Y, Zhou J, Wang L, Wu X, Chen Y, Piao H, Lu L, Jiang W, Xu Y, Feng B, Nan Y, Xie W, Chen G, Zheng H, Li H, Ding H, Liu H, Lv F, Shao C, Wang T, Ou X, Wang B, Chen S, Wee A, Theise ND, You H and Jia J:New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment. Hepatology 2017; 65(5): 1438 – 1450.

Tsutsumi Y, Serizawa A and Kawai K: Enhanced polymer one-step staining (EPOS) for proliferating cell nuclear antigen (PCNA) and Ki-67 antigen: Application to intra-operative frozen diagnosis. Pathol. Int. 1995; 45(2): 108 – 115.

Ohara M, Ohnishi S, Hosono H, Yamamoto K, Fu Q, Maehara O, Suda G, Sakamoto N: Palmitoylethanolamide ameliorates carbon tetrachlorideinduced liver fibrosis in rats. Front. Pharmacol. 2018: 9: 709-713.

Hernandez-Gea V and Friedman SL: Pathogenesis of liver fibrosis. Annu. Rev. Pathol. Mech. Dis. 2011; 6(1): 425 – 456.

Liu H, Zhang Z, Hu H, Zhang C, Niu M, Li R, Wang J, Bai Z, Xiao X: Protective effects of Liuweiwuling tablets on carbon tetrachloride-induced hepatic fibrosis in rats. BMC Complement. Altern. Med. 2018; 18(1): 212218.

Bu FT: SENP2 alleviates CCl 4 -induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion. Toxicol. Lett. 2018; 289; 86 – 98.

Bai F, Huang Q, Wei J, Lv S, Chen Y, Liang C, Wei L, Lu Z, Lin X: Gypsophila elegans isoorientin-2 ″ -O- α - l -arabinopyranosyl ameliorates porcine serum-induced immune liver fibrosis by inhibiting NF- κ B signaling pathway and suppressing HSC activation. Int. Immunopharmacol. 2018; 54: 60 – 67.

Bhondave PD, Devarshi PP, Mahadik KR and Harsulkar AM: Ashvagandharishta’ prepared using yeast consortium from Woodfordia fruticosa flowers exhibit hepatoprotective effect on CCl4 induced liver damage in Wistar rats. J. Ethnopharmacol. 2014; 151(1): 183 – 190.

Karakus E, Karadeniz A, Simsek N, Can I, Kara A, Yildirim S, Kalkan Y and Kisa F: Protective effect of Panax ginseng against serum biochemical changes and apoptosis in liver of rats treated with carbon tetrachloride (CCl 4 ). J. Hazard. Mater. 2011; 195: 208 – 213.

Kweon SM, Chi F, Higashiyama R, Lai K and Tsukamoto H: Wnt pathway stabilizes MeCP2 protein to repress PPAR- γ in activation of hepatic stellate cells. PLoS One 2016; 11(5): e0156111 – e0156119.

He J, Bai K, Hong B, Zhang F, and Zheng S: Docosahexaenoic acid attenuates carbon tetrachloride-induced hepatic fibrosis in rats. Int. Immunopharmacol. 2017; 53: 56 – 62.

Prabhakar P, Reeta KH, Maulik SK, Dinda AK and Gupta YK: Protective effect of thymoquinone against high-fructose diet-induced metabolic syndrome in rats. Eur. J. Nutr. 2015; 54(7): 1117 – 1127.

Lian M, Luo W, Sui Y, Li Z and Hua J: Dietary n-3 PUFA protects mice from con A induced liver injury by modulating regulatory T cells and PPAR- γ expression.PLoS One 2015; 10(7): e0132741 – e0132748.

Liu F, Liu ZD, Wu N, Cong X, Fei R, Chen HS, Wei L: Transplanted endothelial progenitor cells ameliorate carbon tetrachloride-induced liver cirrhosis in rats. Liver Transplant. 2009; 15(9): 1092 – 1100.

Published

05-07-2019
Statistics
275 Views | 293 Downloads

How to Cite

Eman Gouda Khedr, G. M. Al-Ashmawy, S. E.-S. Abu-Risha, Abla Ebeed, and Marwa Salah. “Effects of Nigella Sativa Oil and Docosahexaenoic Acid on Experimentally-Induced Hepatic Fibrosis in Rats”. Journal of Innovations in Pharmaceutical and Biological Sciences, vol. 6, no. 3, July 2019, pp. 24-29, doi:10.56511/JIPBS.2019.v6.i03.pp24-29.

Issue

Section

Research Article